Boren, J <br/><br/>
Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells.  [electronic resource] 

 -  The Journal of biological chemistry  Oct 2001 
 - 37747-53 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0021-9258 
<br/><br/><label>Standard No.: </label>10.1074/jbc.M105796200  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Benzamides<br/>Carbon--metabolism<br/>Enzyme Inhibitors--pharmacology<br/>Fatty Acids--biosynthesis<br/>Glucose--metabolism<br/>Glucosephosphate Dehydrogenase--metabolism<br/>Hexokinase--metabolism<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--enzymology<br/>Nucleic Acids--biosynthesis<br/>Piperazines--pharmacology<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrimidines--pharmacology<br/>Transketolase--metabolism<br/>Tumor Cells, Cultured